Rheumatology

In a breakthrough study that could reshape long-term treatment strategies for psoriatic arthritis (PsA), researchers have found that a small but significant proportion of patients can achieve and maintain remission without the continued use of disease-modifying antirheumatic drugs (DMARDs).

In a landmark systematic review and meta-analysis, researchers have shed new light on the optimal timing for mobilization following open reduction and internal fixation (ORIF) of hand fractures.

Healthcare professionals working with people with inflammatory arthritis (IA) report that emotional, economic and social barriers significantly impact patients’ ability to stay employed.

Rheumatoid arthritis (RA) has long been linked to increased cardiovascular disease risk, and new findings using speckle tracking strain ultrasonography reveal the extent of subclinical vascular damage in this patient population.

In a new analysis of U.S. postmenopausal women, researchers have uncovered a striking U-shaped relationship between reproductive timing and osteoarthritis (OA) risk, suggesting that the spacing between childbirths and maternal age at delivery could influence long-term joint health.

Improving communication between nurses is critical to patient safety and care quality, particularly in complex specialties like rheumatology and immunology.

Understanding referral patterns in rheumatic disease management is crucial to improving interdisciplinary care and patient outcomes.

In patients with rheumatoid arthritis (RA), understanding the risk of venous thromboembolism (VTE) is increasingly important as treatment strategies evolve.

Juvenile idiopathic arthritis (JIA), the most common chronic rheumatic disease in children, may carry underrecognized risks for endocrine dysfunction, according to a new study that highlights significant growth and hormonal disturbances in this vulnerable population.

Chronic insomnia, already known for its toll on mental and physical health, has now been linked to an increased risk of developing specific autoimmune diseases, according to a recent large-scale cohort study conducted in the United States.

In Japan, home to the world’s most rapidly aging society, managing rheumatoid arthritis (RA) in elderly patients has posed unique challenges for healthcare providers.

Multimorbidity, the presence of multiple co-existing health conditions, has emerged as a critical factor influencing survival and physical function in patients with systemic sclerosis (SSc), according to a large cohort study of 2,000 participants.

New research reveals that adults with rheumatoid arthritis (RA) are significantly more likely to develop sleep disorders, including insomnia, than those without the disease, a finding that raises important questions for rheumatologists and primary care providers.

New U.S. data analyzing 90-day outcomes after nonelective total hip arthroplasty (THA) for hip fracture reveals that male patients and those with pre-existing comorbidities face significantly higher risks of readmission and in-hospital mortality.

In a randomized trial, researchers evaluated two physical therapy approaches—high-intensity laser therapy (HILT) and short-wave diathermy (SWD), each combined with exercise, for treating patients with Stage 2–3 knee osteoarthritis.

In older adults with newly diagnosed late-onset rheumatoid arthritis (LORA), long-term glucocorticoid (GC) use remains persistent for a notable subset, according to a new analysis of national Medicare data spanning nearly a decade.

In patients with systemic sclerosis (SSc), the presence of calcinosis cutis, abnormal calcium deposits in the skin, may signal a deeper issue tied to osteoclastogenesis, the formation of bone-resorbing cells, according to a new study.

Healthcare professionals in the U.S. are closely watching progress in the diagnosis and management of IgG4-related periaortitis, periarteritis, and retroperitoneal fibrosis, a complex subset of IgG4-related disease (IgG4-RD) that mimics other conditions and defies simple diagnostic approaches.

A new prospective cohort study has found that the rate of skin thickening progression in patients with systemic sclerosis (SSc), measured using the modified Rodnan skin score (mRSS), is closely correlated with the early onset of serious cardiopulmonary complications, including interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH).

A new study examining the long-term effects of a specific carbohydrate diet (SCD) in children with juvenile idiopathic arthritis (JIA) suggests potential benefits, particularly for individuals seeking to avoid medication escalation.

AI is making significant strides in the diagnosis and outcome prediction of vasculitides, rare inflammatory disorders that can be challenging to identify due to their diverse clinical presentations.

Children with juvenile idiopathic arthritis (JIA) face more than just joint pain, emerging research reveals that the condition may significantly delay puberty.

Adipose-derived stem cells (ADSCs) may offer a groundbreaking new approach to treating systemic sclerosis (SSc), according to a recent study.

A recent analysis of the SENSCIS and SENSCIS-ON trials has demonstrated that nintedanib effectively slows the decline in forced vital capacity (FVC) among patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

A recent study conducted with the UK Medical Cannabis Registry evaluated the impact of cannabis-based medicinal products (CBMPs) on patients suffering from chronic pain due to hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS).

AI is emerging as a promising tool in the diagnosis and management of vasculitides, a group of rare inflammatory disorders that pose significant diagnostic challenges.

The psychometric properties of the Scleroderma Skin Questionnaire (SSQ), a novel patient-reported outcome (PRO) designed to assess skin disease in patients with systemic sclerosis (SSc), has been evaluated in a new study.

A recent long-term population study from Western Australia has revealed critical insights into the relationship between rheumatoid arthritis (RA) and cancer outcomes.

A recent analysis from the RESOLVE-1 trial has highlighted the potential of mycophenolate mofetil (MMF) in treating diffuse cutaneous systemic sclerosis (dcSSc), particularly in early-stage disease.

Inflammation is increasingly recognized as a pivotal factor in the development of atherosclerosis and its associated thrombotic complications.

Explore the efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease, highlighting potential risks like deep vein thrombosis.

Gastroesophageal (GE) symptoms, such as acid reflux and heartburn, are significantly associated with higher disease activity in patients with rheumatoid arthritis (RA), according to a new study.